Quantcast

Latest Peripheral neuropathy Stories

2014-10-22 20:23:18

LONDON, Oct. 22, 2014 /PRNewswire/ -- Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014 SummaryGlobalData's clinical trial report, "Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014" provides data on the Chemotherapy Induced Peripheral Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chemotherapy Induced Peripheral Neuropathy. It includes an...

2014-10-20 08:32:09

NEW YORK and RALEIGH, N.C., Oct. 20, 2014 /PRNewswire/ -- BioPontis Alliance for Rare Disease and the Hereditary Neuropathy Foundation (HNF), both philanthropies, announced today the creation of a joint venture to develop drug candidates for the treatment of the rare disease known as Charcot- Marie-Tooth (CMT) Disease. http://photos.prnewswire.com/prnvar/20141019/152981LOGO BioPontis Alliance announced its alliance model earlier this month. Today's partnership announcement with HNF...

2014-10-08 16:26:39

Research conducted on slaughterhouse workers with chronic pain symptoms. AKRON, Ohio, Oct. 8, 2014 /PRNewswire/ -- Researchers at the National Research Centre for the Working Environment in Copenhagen, Denmark compared the effectiveness of Biofreeze(®) topical analgesic and a placebo gel on reducing chronic pain and symptoms of carpal tunnel syndrome in slaughterhouse workers. Compared to the placebo gel, Biofreeze Pain Reliever reduced hand/wrist pain by 31%. Carpal tunnel...

2014-09-30 23:13:38

Evidence Based Rehab Techniques for Parkinsons, Multiple Sclerosis and Peripheral Neuropathy is a new OT PT Continuing Education courses designed to deliver new rehab information on the treatment of Multiple Sclerosis and Peripheral Neuropathy. Franklin, TN (PRWEB) September 30, 2014 Neuromuscular and central nervous system diseases affect millions of people throughout the United States and worldwide. It is estimated that 50,000-60,000 new cases of Parkinson’s Disease are diagnosed each...

2014-09-26 23:03:30

MarketOptimizer.org adds “PharmaPoint: Neuropathic Pain - Global Drug Forecast and Market Analysis to 2022” to its store. Novel Therapies to Revitalize the Neuropathic Pain Treatment Market Landscape by 2022. Dallas, Texas (PRWEB) September 26, 2014 With seven promising neuropathic pain (NP) treatments expected to be launched in the coming years, the NP therapeutics market value - covering painful diabetic neuropathy, postherpetic neuralgia and trigeminal neuralgia - is forecast to...

2014-09-26 12:23:14

CINCINNATI, Sept. 26, 2014 /PRNewswire-USNewswire/ -- New research shows that disrupting the molecular function of a tumor suppressor causes improper formation of a protective insulating sheath on peripheral nerves - leading to neuropathy and muscle wasting in mice similar to that in human diabetes and neurodegeneration. http://photos.prnewswire.com/prnvar/20110406/MM79025LOGO Scientists from Cincinnati Children's Hospital Medical Center report their findings online Sept. 26 in...

2014-09-25 23:02:03

A breakthrough program by Dr. Karl R.O.S. Johnson, DC, of Shelby Township, Mich., is helping sufferers of peripheral neuropathy resolve health challenges without traditional medications. Johnson will be discussing his innovative neuropathy protocol at a free seminar on September 30 at 6:30 p.m. at the Shelby Township Community Center. SHELBY TOWNSHIP, Mich. (PRWEB) September 25, 2014 Dr. Karl R.O.S. Johnson, DC, is pleased to announce a breakthrough program of care that gives people who...

2014-09-19 12:25:14

NEW YORK, Sept. 19, 2014 /PRNewswire-USNewswire/ -- An entire month is dedicated to one of the most common forms of inherited neuropathies - Charcot-Marie-Tooth disease (CMT) - a debilitating neuromuscular disease affecting the arms, hands, feet and legs, causing extreme muscle atrophy, weakness, and foot and hand deformities. CMT affects 1 in 2,500 in the US and millions worldwide. CMT is a progressive disease, and over time patients lose the normal use of their legs, requiring mobility...

2014-09-17 12:27:24

MUMBAI, India, September 17, 2014 /PRNewswire/ -- - Glenmark's first in class TRPA1 antagonist, GRC 17536, has shown positive data in a Phase 2a proof of concept study in patients with painful diabetic neuropathy Glenmark Pharmaceuticals today announced that its first in class Transient Receptor Potential Ankyrin 1 (TRPA1) antagonist, GRC 17536 has shown positive data in a Phase 2a double blind, placebo controlled, multi-centre, proof of concept...

2014-09-16 04:21:15

PARIS and NEW YORK, Sept. 16, 2014 /PRNewswire/ -- The French biopharmaceutical company Pharnext SAS and the Hereditary Neuropathy Foundation (HNF) announced today an agreement to collaborate on programs to increase the awareness around Charcot-Marie-Tooth (CMT) disease and support the development of a stronger CMT patient and research community. Pharnext will provide financial support to several HNF's initiatives including: -- Enhanced design and development of a specific section in...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related